Medical Device Design Flaws for Children With Medical Complexity at Home

Peter Walsh1, Sofia Seewald1, Leo Castillo1

  • 1Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Pediatrics
|February 9, 2026
PubMed

Insights

Parents of children with medical complexity (CMC) report significant issues with in-home medical devices, including design flaws and access barriers. These problems can lead to safety risks and impact health outcomes for CMC.

Area of Science:

  • Pediatric Healthcare
  • Biomedical Engineering
  • Health Services Research

Background:

  • Children with medical complexity (CMC) represent a growing population requiring extensive home-based medical devices and supplies.
  • Existing home medical devices have been linked to adverse events, including emergency care visits and hospitalizations.
  • Understanding parent experiences is crucial for improving the safety and efficacy of these essential technologies.

Purpose of the Study:

  • To investigate the lived experiences of parents managing in-home medical devices for children with medical complexity (CMC).
  • To identify specific challenges, unmet needs, and desired improvements in the design and accessibility of these devices.
  • To uncover opportunities for enhancing the support systems surrounding home medical device use for CMC.

Main Methods:

  • A qualitative, cross-sectional study involving semistructured interviews with parents of CMC.
  • Inclusion of photographic evidence and descriptions of device use to supplement interview data.
  • Application of thematic and content analysis to identify recurring themes and design preferences.

Main Results:

  • Five primary themes emerged: inadequate communication regarding product availability, frequent and significant device design flaws posing safety risks, parental improvisation to overcome device limitations, structural barriers to accessing quality devices, and specific valued design attributes.
  • Seventeen interviews and 97 submitted images provided rich qualitative data.
  • Parents actively engaged in problem-solving due to device shortcomings.

Conclusions:

  • The current provision of in-home medical devices for CMC is insufficient, presenting safety concerns and negatively impacting patient health.
  • Medical device design flaws are a significant issue, potentially compromising the well-being of CMC.
  • Future interventions must integrate parental feedback into medical product design and coverage policies to better meet the needs of CMC.
Abstract

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
818
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
266
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
221
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
369
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
356
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
312